Pörssitiedote08.01.2025 klo 23.19Ziccum resolves on a directed issue of shares and provides an update on its financial situation
Pörssitiedote30.12.2024 klo 09.30Ziccum’s rights issue registered – conversion of BTU into shares and warrants
Lehdistötiedote06.12.2024 klo 10.00CEO interview on current industry dialogues and business development
Lehdistötiedote03.12.2024 klo 09.30Ziccum unveils an innovative prototype for dried powder separation and collection
Lehdistötiedote27.11.2024 klo 10.00Ziccum CEO holds a Q&A session regarding current activities and dialogues
Pörssitiedote15.11.2024 klo 00.05The board of directors of Ziccum has resolved on a previously announced rights issue of units of approximately SEK 30 million
Pörssitiedote14.11.2024 klo 18.45Ziccum has appointed a nomination committee for the 2025 annual general meeting
Lehdistötiedote13.11.2024 klo 17.50Ziccum reports good progress in the project for inhalable mRNA/LNP
Lehdistötiedote04.11.2024 klo 12.00Ziccum AB: Ziccum will present at the BioStock Life Science Summit, November 21
Lehdistötiedote01.11.2024 klo 10.00Analyst interview in Swedish with Ziccum's CEO following the release of Q3, 2024 report